Related Experiment Videos
Hyponatremia associated with 3,4-methylenedioxymethylamphetamine ("Ecstasy") abuse
Milos N Budisavljevic1, Lisa Stewart, Steven A Sahn
1Nephrology Division, Division of Pulmonary and Critical Care Medicine, Medical University of South Carolina, 171 Ashley Avenue, Charleston, NC 29425, USA. budisamn@musc.edu
The American Journal of the Medical Sciences
|August 16, 2003
Summary
Acute hyponatremia, a dangerous drop in sodium, can occur after using 3,4-methylenedioxymethylamphetamine (MDMA). Young women are especially at risk, and this condition can be fatal.
Area of Science:
- Toxicology
- Endocrinology
- Neurology
Background:
- 3,4-methylenedioxymethylamphetamine (MDMA), or "ecstasy," is a recreational drug associated with various health risks.
- Hyponatremia, a condition characterized by low sodium levels in the blood, can be severe and life-threatening.
Observation:
- A case study of a young woman who developed acute, symptomatic hyponatremia following MDMA use.
- The patient experienced complete recovery after treatment with 5% saline.
Findings:
- MDMA-associated hyponatremia is linked to excessive water intake and elevated antidiuretic hormone (ADH) levels.
- Young, premenopausal women appear to be a high-risk group for severe hyponatremia after MDMA use.
- Literature review identified four fatal cases of MDMA-associated hyponatremia, all in women, resulting in cerebellar tonsillar herniation.
Implications:
- Acute hyponatremia following MDMA use is a potentially life-threatening condition.
- Recommendations for MDMA users to drink large volumes of water may be inappropriate and increase risk.
- Clinicians should be aware of the risk of severe hyponatremia in MDMA users, particularly young women.